Monsanto Company Second Quarter Earnings Sneak Peek

S&P 500 (NYSE:SPY) component Monsanto Company (NYSE:MON) will unveil its latest earnings on Wednesday, April 4, 2012. Monsanto manufactures agricultural products.

Monsanto Company Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for net income of $2.11 per share, a rise of 12.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $2.10. Between one and three months ago, the average estimate moved up. It has been unchanged at $2.11 during the last month. Analysts are projecting profit to rise by 18.6% compared to last year’s $3.51.

Past Earnings Performance: Last quarter, the company beat estimates by 4 cents, coming in at profit of 23 cents a share versus the estimate of net income of 19 cents a share. It marked the fourth straight quarter of beating estimates.

Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?

Wall St. Revenue Expectations: On average, analysts predict $4.53 billion in revenue this quarter, a rise of 9.7% from the year-ago quarter. Analysts are forecasting total revenue of $12.94 billion for the year, a rise of 9.5% from last year’s revenue of $11.82 billion.

A Look Back: In the first quarter, profit rose to $126 million (23 cents a share) from $6 million (one cent a share) the year earlier, exceeding analyst expectations. Revenue rose 33.3% to $2.44 billion from $1.83 billion.

Key Stats:

On the top line, the company is looking to extend some positive momentum with this earnings announcement. Revenue rose 6.1% in the second quarter of the last fiscal year, 21.2% in the third quarter of the last fiscal year and 16.4% in the fourth quarter before climbing again in the first quarter.

Stock Price Performance: Between January 3, 2012 and March 29, 2012, the stock price rose $7.27 (10.1%), from $71.64 to $78.91. The stock price saw one of its best stretches over the last year between December 30, 2011 and January 12, 2012, when shares rose for nine straight days, increasing 15% (+$10.49) over that span. It saw one of its worst periods between September 15, 2011 and September 23, 2011 when shares fell for seven straight days, dropping 9.5% (-$6.65) over that span.

Analyst Ratings: Optimism surrounds Monsanto Company, as 10 analysts rate it as a buy, one rates it as a sell, and seven rate it as a hold.

(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)

Don’t Miss These Additional Hot Stories:

Will Monetary Policy and Inflation Continue to Support Gold?

America’s Big Appetite is Good for These Restaurant Stocks

Here’s How ‘Hunger Games’ Blew Everyone Out of the Water

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at